Evidence map›Paper›PMID 24007883›Full record

ReviewThe American journal of pathology2013

New insights into the pathology of podocyte loss: mitotic catastrophe.

Helen Liapis, Paola Romagnani, Hans-Joachim Anders

Open access · bronzeAbstract readReview
In one paragraph

Review in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 121 citations in OpenAlex.

  1. USP40 protects podocytes by deubiquitylating integrin β1.Biochemical and biophysical research communications · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. The Life of a Kidney Podocyte.Acta physiologica (Oxford, England) · 2025
    Review
  6. Molecular therapy. Nucleic acids · 2025
    Article
  7. Review
  8. Review
  9. Piezo1, F-Actin Remodeling, and Podocyte Survival and Regeneration.Journal of the American Society of Nephrology : JASN · 2025
    Article
  10. Podocytes in health and glomerular disease.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Mice with aAmerican journal of physiology. Renal physiology · 2024
    Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 4 countries.

Helen LiapisDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri; Department of Internal Medicine (Renal), Washington University School of Medicine, St. Louis, Missouri. Electronic address: liapis@path.wustl.edu.
Paola RomagnaniExcellence Centre for Research, Transfer and High Education for the Development of de Novo Therapies (DENOTHE), Florence, Italy; Pediatric Nephrology Unit, Meyer Children's Hospital, Florence, Italy.
Hans-Joachim AndersNephrology Center, Medical Hospital and Health Center IV, University of Munich Clinical Center-LMU, Campus Innenstadt, Munich, Germany.
Ludwig-Maximilians-Universität München · DEMeyer Children's Hospital · ITWashington University in St. Louis · US

Funding

PHS HHS NIDDK079333
6 · The paper itself

Abstract

Podocytes represent an essential component of the kidney's glomerular filtration barrier. They stay attached to the glomerular basement membrane via integrin interactions that support the capillary wall to withstand the pulsating filtration pressure. Podocyte structure is maintained by a dynamic actin cytoskeleton. Terminal differentiation is coupled with permanent exit from the cell cycle and arrest in a postmitotic state. Postmitotic podocytes do not have an infinite life span; in fact, physiologic loss in the urine is documented. Proteinuria and other injuries accelerate podocyte loss or induce death. Mature podocytes are unable to replicate and maintain their actin cytoskeleton simultaneously. By the end of mitosis, cytoskeletal actin forms part of the contractile ring, rendering a round shape to podocytes. Therefore, when podocyte mitosis is attempted, it may lead to aberrant mitosis (ie, mitotic catastrophe). Mitotic catastrophe implies that mitotic podocytes eventually detach or die; this is a previously unrecognized form of podocyte loss and a compensatory mechanism for podocyte hypertrophy that relies on post-G1-phase cell cycle arrest. In contrast, local podocyte progenitors (parietal epithelial cells) exhibit a simple actin cytoskeleton structure and can easily undergo mitosis, supporting podocyte regeneration. In this review we provide an appraisal of the in situ pathology of mitotic catastrophe compared with other proposed types of podocyte death and put experimental and renal biopsy data in a unified perspective.

Indexed as

MitosisAnimalsCell DeathHIV InfectionsHumansHypertrophyKidney DiseasesPodocytes

Identifiers

PMID24007883
PMCPMC3814687
OpenAlexW4482768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.